Skip to main content
. Author manuscript; available in PMC: 2022 May 24.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2019 Apr 26;19(7):e400–e405. doi: 10.1016/j.clml.2019.04.007

Figure 1.

Figure 1.

a) Overall survival in patients carrying and not carrying IDH mutations and b) Relapse rate in patients carrying and not carrying IDH mutations.